These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2110877)

  • 41. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of three controlled trials.
    Dahl SL; Samuelson CO; Williams HJ; Ward JR; Karg M
    Pharmacotherapy; 1990; 10(2):79-84. PubMed ID: 2112243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis.
    Williams HJ; Ward JR; Dahl SL; Clegg DO; Willkens RF; Oglesby T; Weisman MH; Schlegel S; Michaels RM; Luggen ME
    Arthritis Rheum; 1988 Jun; 31(6):702-13. PubMed ID: 2898244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
    Lehman AJ; Esdaile JM; Klinkhoff AV; Grant E; Fitzgerald A; Canvin J;
    Arthritis Rheum; 2005 May; 52(5):1360-70. PubMed ID: 15880810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin.
    Tumiati B; Veneziani M; Bellelli A; Portioli I
    J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794
    [No Abstract]   [Full Text] [Related]  

  • 46. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial.
    van Dongen H; van Aken J; Lard LR; Visser K; Ronday HK; Hulsmans HM; Speyer I; Westedt ML; Peeters AJ; Allaart CF; Toes RE; Breedveld FC; Huizinga TW
    Arthritis Rheum; 2007 May; 56(5):1424-32. PubMed ID: 17469099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adverse reactions to parenteral gold salts.
    Tilelli JA; Heinrichs MM
    Lancet; 1997 Mar; 349(9055):853. PubMed ID: 9121270
    [No Abstract]   [Full Text] [Related]  

  • 48. Maintenance chrysotherapy in rheumatoid arthritis: a comparison of 2 dose schedules.
    Griffin AJ; Gibson T; Huston G; Taylor A
    Ann Rheum Dis; 1981 Jun; 40(3):250-3. PubMed ID: 6787995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peripheral lymphocyte depletion in gold sodium thiomalate-treated rheumatoid arthritis patients.
    Lundberg MS; Cannon GW; Ward JR
    Arthritis Rheum; 1988 Jul; 31(7):909-13. PubMed ID: 3134898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum gold. II. Levels in rheumatoid arthritis.
    Rubinstein HM; Dietz AA
    Ann Rheum Dis; 1973 Mar; 32(2):128-32. PubMed ID: 4266407
    [No Abstract]   [Full Text] [Related]  

  • 51. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
    Kovarsky J
    Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
    [No Abstract]   [Full Text] [Related]  

  • 52. A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis.
    Thompson RN; Watts C; Edelman J; Esdaile J; Russell AS
    J Rheumatol; 1984 Dec; 11(6):760-3. PubMed ID: 6394758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 2000 Jul; 42(1082):57-64. PubMed ID: 10887424
    [No Abstract]   [Full Text] [Related]  

  • 54. Myocrisin.
    Capell HA
    Agents Actions Suppl; 1988; 24():158-66. PubMed ID: 3142232
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.
    Bakker MF; Jacobs JW; Welsing PM; Verstappen SM; Tekstra J; Ton E; Geurts MA; van der Werf JH; van Albada-Kuipers GA; Jahangier-de Veen ZN; van der Veen MJ; Verhoef CM; Lafeber FP; Bijlsma JW;
    Ann Intern Med; 2012 Mar; 156(5):329-39. PubMed ID: 22393128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Localized lymphoma in a patient with rheumatoid arthritis treated with parenteral methotrexate.
    Morris CR; Morris AJ
    J Rheumatol; 1993 Dec; 20(12):2172-3. PubMed ID: 8014957
    [No Abstract]   [Full Text] [Related]  

  • 58. High dose intravenous methotrexate for refractory rheumatoid arthritis.
    Shiroky JB; Neville C; Skelton JD
    J Rheumatol; 1992 Feb; 19(2):247-51. PubMed ID: 1629823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
    Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
    J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Reactions against sodium-auro-thiomalate in the treatment of rheumatoid arthritis].
    Cruz Filho A; Gomes IJ; Budaruiche JS
    Z Rheumatol; 1979; 38(9-10):381-4. PubMed ID: 118603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.